Gordanpour Aida, Nam Robert K, Sugar Linda, Bacopulos Stephanie, Seth Arun
Department of Laboratory Medicine & Pathobiology, University of Toronto.
J Vis Exp. 2012 May 16(63):e3874. doi: 10.3791/3874.
MicroRNAs (miRNAs) are single-stranded, 18-24 nucleotide long, non-coding RNA molecules. They are involved in virtually every cellular process including development, apoptosis, and cell cycle regulation. MiRNAs are estimated to regulate the expression of 30% to 90% of human genes by binding to their target messenger RNAs (mRNAs). Widespread dysregulation of miRNAs has been reported in various diseases and cancer subtypes. Due to their prevalence and unique structure, these small molecules are likely to be the next generation of biomarkers, therapeutic agents and/or targets. Methods used to investigate miRNA expression include SYBR green I dye-based as well as Taqman-probe based qPCR. If miRNAs are to be effectively used in the clinical setting, it is imperative that their detection in fresh and/or archived clinical samples be accurate, reproducible, and specific. qPCR has been widely used for validating expression of miRNAs in whole genome analyses such as microarray studies. The samples used in this protocol were from patients who underwent radical prostatectomy for clinically localized prostate cancer; however other tissues and cell lines can be substituted in. Prostate specimens were snap-frozen in liquid nitrogen after resection. Clinical variables and follow-up information for each patient were collected for subsequent analysis. Quantification of miRNA levels in prostate tumor samples. The main steps in qPCR analysis of tumors are: Total RNA extraction, cDNA synthesis, and detection of qPCR products using miRNA-specific primers. Total RNA, which includes mRNA, miRNA, and other small RNAs were extracted from specimens using TRIzol reagent. Qiagen's miScript System was used to synthesize cDNA and perform qPCR (Figure 1). Endogenous miRNAs are not polyadenylated, therefore during the reverse transcription process, a poly(A) polymerase polyadenylates the miRNA. The miRNA is used as a template to synthesize cDNA using oligo-dT and Reverse Transcriptase. A universal tag sequence on the 5' end of oligo-dT primers facilitates the amplification of cDNA in the PCR step. PCR product amplification is detected by the level of fluorescence emitted by SYBR Green, a dye which intercalates into double stranded DNA. Specific miRNA primers, along with a Universal Primer that binds to the universal tag sequence will amplify specific miRNA sequences. The miScript Primer Assays are available for over a thousand human-specific miRNAs, and hundreds of murine-specific miRNAs. Relative quantification method was used here to quantify the expression of miRNAs. To correct for variability amongst different samples, expression levels of a target miRNA is normalized to the expression levels of a reference gene. The choice of a gene on which to normalize the expression of targets is critical in relative quantification method of analysis. Examples of reference genes typically used in this capacity are the small RNAs RNU6B, RNU44, and RNU48 as they are considered to be stably expressed across most samples. In this protocol, RNU6B is used as the reference gene.
微小RNA(miRNA)是单链的、长度为18 - 24个核苷酸的非编码RNA分子。它们几乎参与了每一个细胞过程,包括发育、细胞凋亡和细胞周期调控。据估计,miRNA通过与靶信使RNA(mRNA)结合来调节30%至90%的人类基因的表达。在各种疾病和癌症亚型中都报道了miRNA的广泛失调。由于它们的普遍性和独特结构,这些小分子很可能成为下一代生物标志物、治疗剂和/或靶点。用于研究miRNA表达的方法包括基于SYBR绿I染料的以及基于Taqman探针的定量聚合酶链反应(qPCR)。如果要在临床环境中有效使用miRNA,那么在新鲜和/或存档的临床样本中对它们的检测必须准确、可重复且具有特异性。qPCR已广泛用于在全基因组分析(如微阵列研究)中验证miRNA的表达。本方案中使用的样本来自因临床局限性前列腺癌接受根治性前列腺切除术的患者;然而,其他组织和细胞系也可以替代。前列腺标本在切除后立即在液氮中速冻。收集每个患者的临床变量和随访信息以供后续分析。前列腺肿瘤样本中miRNA水平的定量。肿瘤qPCR分析的主要步骤包括:总RNA提取、cDNA合成以及使用miRNA特异性引物检测qPCR产物。使用TRIzol试剂从标本中提取包括mRNA、miRNA和其他小RNA的总RNA。使用Qiagen的miScript系统合成cDNA并进行qPCR(图1)。内源性miRNA没有聚腺苷酸化,因此在逆转录过程中,一种聚腺苷酸聚合酶会给miRNA加上聚腺苷酸尾巴。使用寡聚dT和逆转录酶以miRNA为模板合成cDNA。寡聚dT引物5'端的通用标签序列有助于在PCR步骤中扩增cDNA。通过SYBR Green发出的荧光水平检测PCR产物的扩增,SYBR Green是一种可插入双链DNA的染料。特异性miRNA引物以及与通用标签序列结合的通用引物将扩增特定的miRNA序列。miScript引物检测可用于一千多种人类特异性miRNA和数百种小鼠特异性miRNA。这里使用相对定量方法来定量miRNA的表达。为了校正不同样本之间的变异性,将靶miRNA的表达水平标准化为参考基因的表达水平。在相对定量分析方法中,选择用于标准化靶标表达的基因至关重要。通常用于此目的的参考基因示例是小RNA RNU6B、RNU44和RNU48,因为它们被认为在大多数样本中稳定表达。在本方案中,使用RNU6B作为参考基因。